glp-1 and liver cirrhosis Multiple target tissue effects of analogues on non-alcoholic fatty disease (NAFLD) non-alcoholic steatohepatitis (NASH) GLP-1 Agonists May Lower Cirrhosis,

Similar content being viewed by others Introduction Glucagon-like-peptide-1 (GLP-1) is a metabolic hormone secreted by intestinal endocrine L-cells and stimulates insulin secretion in a glucose-dependent manner [1]

The MAP is intended to ensure that treatment is prioritised for those most likely to benefit and at highest clinical risk

doi: 10.1038/s41586-024-07685-6

doi: 10.3390/biomedicines9121853

GLP-1 GIP GLP-1 GIP 2 2 GLP-1 GLP-1 (Glucagon-like Peptide-1) ( The New England Journal of Medicine ) GLP-1 () GIP GIP (Glucose-dependent Insulinotropic Polypeptide) GIP ( The Lancet) GIP GLP-1 GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP Semaglutide (Slimera, Wegovy) Tirzepatide (Mounjaro) GLP-1 GIP GLP-1 GIP GLP-1 GIP GLP-1 GIP (References) Drucker, D

Leafy Greens Leafy greens like spinach, kale, and Swiss chard are not just full of essential vitamins and minerals, but they are also thought to boost GLP-1 secretion